N@N

Market Maker Surveillance Report. VSCI, ABT, TRIT, CBPO, SKUL, UGAZ, Losing Stocks With Lowest Price Friction For Wednesday, J

January 2, 2013 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4224 companies with "abnormal" market making, 4536 companies with positive Friction Factors and 953 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Wednesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Vision Sciences Inc (NASDAQ:VSCI), ABBOTT LABORATORIES (NYSE:ABT), Tri-Tech Holding Inc (NASDAQ:TRIT), China Biologic Products Inc (NASDAQ:CBPO), Skullcandy Inc (NASDAQ:SKUL), (NYSE:UGAZ). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  VSCI    $-0.140   -11.76%   29,309       39.71%    44,505       60.29%    -15,196      -1,085  
  ABT     $-33.390  -50.98%   4,878,747    24.11%    6,352,982    31.40%    -1,474,235   -442    
  TRIT    $-0.300   -10.91%   64,248       40.09%    93,156       58.13%    -28,908      -964    
  CBPO    $-1.600   -9.81%    75,264       46.59%    85,970       53.22%    -10,706      -67     
  SKUL    $-1.040   -13.35%   1,532,078    46.09%    1,772,149    53.31%    -240,071     -2,308  
  UGAZ    $-2.410   -11.02%   419,724      31.37%    533,095      39.84%    -113,371     -470    

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows VSCI with a dollar loss Wednesday of $-0.14000 and a Friction Factor of -1,085 shares. That means that it only took 1,085 more shares of selling than buying to move VSCI lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

Vision Sciences Inc (NASDAQ:VSCI) - Vision-Sciences, Inc. designs, develops, manufactures, and markets products for endoscopy. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, and sells a line of endoscopy-based products, including flexible endoscopes and sheath or EndoSheath disposables primarily to the ENT, urology, gastroenterology, and pulmonology markets. The Industrial segment designs, manufactures, and markets flexible borescopes under the Machida brand name. This segment offers various products, such as modulars, slim levers, knobs, battery operated portable flexible borescopes, industrial videoscopes, and portable video processors primarily to the aircraft engine manufacturing and aircraft engine maintenance industries. The company offers its products to the ENT doctors, urologists, gastroenterologists, primary care physicians, pulmonologists and other airway management doctors in hospitals, medical clinics, and physicians private offices. It provides its products through sales representatives in the United States; and through independent distributors in Europe, Asia, Australia, Canada, the Middle East, Africa, and Central and South America. The company was founded in 1987 and is based in Orangeburg, New York..

ABBOTT LABORATORIES (NYSE:ABT) - Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. It operates in four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. The Pharmaceutical Products segment offers adult and pediatric pharmaceuticals for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis, Crohn's disease, dyslipidemia, HIV infection, hypothyroidism, advanced prostate cancer, endometriosis and central precocious puberty, anemia, obesity, epilepsy and bipolar disorder, migraines, secondary hyperparathyroidism, gastroesophageal reflux disease, duodenal and gastric ulcers, and erosive esophagitis, as well as provides anesthesia products and anti-infectives. The Diagnostic Products segment offers immunoassay systems; chemistry systems; assays used for screening and/or diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, physiological, and infectious diseases; instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infections agents; genomic-based tests; hematology systems and reagents; and point-of-care diagnostic systems and tests for blood analysis. The Nutritional Products segment provides a line of pediatric and adult nutritional products. The Vascular Products segment offers coronary, endovascular, and vessel closure devices, such as drug-eluting coronary stent systems, coronary metallic stents, balloon dilatation products, coronary guidewires, vessel closure devices, and carotid stent systems to treat vascular disease. Additionally, the company provides blood glucose monitoring meters, test strips, data management software, and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, lasik surgery, contact lens, and dry eye products. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois..

Tri-Tech Holding Inc (NASDAQ:TRIT) - Tri-Tech Holding Inc. develops and implements integrated software and hardware solutions to assist Chinese government entities monitor and manage natural and municipal water supplies. The company operates in two segments, Water and Wastewater Treatment Process Control Systems, and Process Tail Gas Purification (Wastewater and Tail Gas Treatment) and Water Resources Protection and Allocation, Flood Control and Forecasting, Irrigation Systems and Municipal Water Supply and Distribution Systems (Water Resource Management). The Wastewater and Tail Gas Treatment segment designs sewage treatment and odor control systems for municipal supplies. These systems allow the clients to monitor and control variables in the sewage treatment and odor control processes. Its technology and products include sewage treatment and water recycling/sewage water pipeline network, sewage water plant/recycling, and recycling. The Water Resource Management segment assists the government in monitoring natural waterways. It provides systems that combine technological solutions to track water levels for drought and flood control, monitor groundwater quality, and assist the government in planning its water resource use and management. This segments technology and products assist its customers to monitor municipal and natural water resources, including drought/flood control, water quality monitoring, water resource utilization and management, and municipal water supply. The company is headquartered in Beijing, the Peoples Republic of China..

China Biologic Products Inc (NASDAQ:CBPO) - China Biologic Products, Inc., a biopharmaceutical company, through its subsidiaries, engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People s Republic of China. It offers Human Albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also offers Human Hepatitis B Immunoglobulin for the prevention of measles and contagious hepatitis; Human Immunoglobulin and Human Immunoglobulin for Intravenous Injection products for original immunoglobulin deficiency, secondary immunoglobulin deficiency, and auto-immune deficiency diseases; and Thymopolypeptides Injection that is used in the treatment of various original and secondary T-cell deficiency syndromes, auto-immune deficiency diseases, and a range of cell immunity deficiency diseases, as well as assists in the treatment for tumors. In addition, it provides Human Rabies Immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; Human Tetanus Immunoglobulin for the prevention and therapy of tetanus; and Placenta Polypeptide that is used for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia caused by various reasons, as well as assists in postoperative heating. The company s products under development comprise Human Prothrombin Complex Concentrate; Human Coagulation Factor VIII; Human Hepatitis B Immunoglobulin (PH4) for Intravenous Injection; Human Fibrinogen; Varicella Hyperimmune Globulins; and Human Immunoglobulin for Intravenous Injection. The company is based in Beijing, the People's Republic of China..

Skullcandy Inc (NASDAQ:SKUL) - .

(NYSE:UGAZ) - .

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net